Lilly Says Lists Prices Rose 3.8% Last Year, Though the Net Prices Tell a More Fascinating Story
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
Every day, I say: this is the day I’ll stop writing about obesity. And every day, at least for about the past week, I break that promise to myself. And
Programming note: No Curve tomorrow. Back Monday. Behave, y’all. We’re in the thick of earnings season, and we had quarterly numbers drop today from Sanofi, AstraZeneca, AbbVie, and Roche. All